{"name":"Abrexa Pharmaceuticals, Inc.","slug":"abrexa-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"Abrexa Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative treatments for serious diseases. The company's lead candidate, J147 Emulsion for Injection, is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"J147 Emulsion for Injection","genericName":"J147 Emulsion for Injection","slug":"j147-emulsion-for-injection","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"J147 Emulsion for Injection","genericName":"J147 Emulsion for Injection","slug":"j147-emulsion-for-injection","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNeTFBejlzQ1RndEwtN3lCa2Rwb3JGQkpNWXhla2ZNSnhzRzhsSml1TThQY0NUMy1JbmpLcFlMenVLa3VyeE9KOTY5VFJFMGNlTjNwYllYMUdUTjE5dXU0c3FYaWNyZUZzLTR2S1kxb00zMGRrZktaWUZyWjNmQUY0aWpBVFJwQQ?oc=5","date":"2025-06-03","type":"earnings","source":"Business San Diego","summary":"Here's the San Diego Startups That Have Raised VC Funding in Q2 2025 (So Far) - Business San Diego","headline":"Here's the San Diego Startups That Have Raised VC Funding in Q2 2025 (So Far)","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}